COSM · XBRL financial data

Cosmos Health financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (COSM's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	55,406	56,240	50,348	53,377	54,426	65,272
Cost of goods and services sold	47,346	47,909	44,391	49,027	50,115	57,376
Gross profit	8,060	8,330	5,957	4,350	4,311	7,896
Research and development	—	—	—	165	533	519
General and administrative	4,185	9,209	10,183	19,642	11,733	15,619
Total operating expenses	5,346	12,864	13,431	26,181	19,856	24,599
Other operating income (expense)	(1,516)	(89)	—	—	—	—
Operating income (loss)	2,714	(4,533)	(7,474)	(21,831)	(15,545)	(16,704)
Interest income	66	—	—	—	—	—
Interest expense	4	2,824	2,345	866	1,012	1,900
Other income (expense)	—	(89)	(2,425)	(66)	87	(233)
Income tax expense (benefit)	378	(114)	775	0	0	0
Net income (loss)	821	(7,962)	(13,830)	(18,543)	(16,183)	(19,145)
Earnings per share, basic USD per share	0.06	(0.95)	(33.16)	(2.15)	(1.17)	(0.63)
Earnings per share, diluted USD per share	0.06	(0.95)	(33.16)	(2.15)	(1.17)	(0.63)
Weighted average shares, basic thousands of shares	13,270	16,423	1,928	11,969	19,148	30,289
Weighted average shares, diluted thousands of shares	13,308	16,423	1,928	—	19,148	30,289

Fiscal years (COSM's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	628	286	20,750	3,833	315	716
Marketable securities	223	7	15	20	21	46
Accounts receivable	—	—	23,692	19,759	13,478	19,629
Inventory	3,293	3,147	3,452	4,789	4,355	5,778
Prepaid and other current assets	5,148	2,992	1,968	1,812	1,310	2,007
Total current assets	40,773	40,879	56,045	36,608	25,461	38,388
Property and equipment, net	1,757	1,881	1,817	10,455	9,690	10,579
Right-of-use asset	834	834	821	1,132	696	597
Goodwill	50	50	50	50	50	50
Total assets	43,844	49,429	68,039	66,015	54,312	65,478
Accrued liabilities	742	1,020	276	166	222	—
Total current liabilities	34,793	29,928	21,749	24,322	25,758	38,272
Long-term debt	—	478	—	1,327	—	—
Lease liability, non-current	591	696	654	845	498	373
Total liabilities	48,005	45,050	28,382	29,972	29,779	47,053
Accumulated deficit	(18,751)	(34,346)	(66,233)	(91,644)	(114,022)	(133,167)
Total stockholders' equity	(4,161)	4,379	39,284	36,043	24,533	18,425
Total liabilities and equity	43,844	49,429	68,039	66,015	54,312	65,478
Common shares outstanding (cover page) thousands of shares	16,067	17,545	10,621	17,606	27,285	50,825

Fiscal years (COSM's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	821	(7,962)	(13,830)	(18,543)	(16,183)	(19,145)
Stock-based compensation	—	5,904	24	578	1,690	2,312
Depreciation and amortization	—	352	103	—	1,219	1,361
Net cash from operating activities	(11,502)	(7,097)	(14,871)	(15,636)	(7,717)	(8,448)
Purchases of property and equipment	118	581	74	1,313	418	56
Net cash from investing activities	(118)	(827)	(21)	(13,760)	(798)	(2,015)
Proceeds from issuing common stock	—	0	35,276	0	649	5,417
Share repurchases	200	377	—	100	0	—
Net cash from financing activities	12,461	7,268	35,048	12,694	5,047	14,056
Net change in cash	590	(342)	20,463	(16,916)	(3,518)	3,145

SIC 5122 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Cosmos Health	1,801	18,986	(1,718)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtech	247	629	(55)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
DataMeds AI	2,456	1,780	(2,894)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
HWH International	1,506	64	478*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.